Immunitas Therapeutics, INC
Waltham, MA
United States
TAP Partner
Immunitas is a single cell genomics-based therapeutics company focused on immunology that is advancing multiple programs to the clinic. Immunitas’ programs are derived from their platform, a cross-functional, highly integrated, single cell genomics approach that enables rapid target identification and validation in parallel with antibody discovery and engineering.
Program Name(s)
Therapy Acceleration Program
![Immunitas](/sites/default/files/styles/inspirational_stories_square/public/2021-10/Immunitas_web_SQ.jpg?itok=yx6PVLbG)